Arnuity Ellipta

January 28, 2015November 6, 2015

GSK Expands Its COPD And Asthma Portfolio Across The US

Asthma, News

GlaxoSmithKline (GSK) recently announced that two of its latest approved products are now available in retail pharmacies across the United States to treat both chronic obstructive pulmonary disease (COPD) and asthma. In the United States over the last ... Read more

August 22, 2014November 6, 2015

FDA Approves GSK’s Drug Arnuity Ellipta to Treat Asthma in the US

Asthma

The U.S. Food and Drug Administration recently approved GlaxoSmithKline‘s treatment of asthma, Arnuity Ellipta (fluticasone furoate inhalation powder), as a prophylactic therapy in patients aged 12 years and older. Arnuity Ellipta is a once-daily ... Read more